Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

A. Ajani, Jaffer; A. D’Amico, Thomas; J. Bentrem, David; Chao, Joseph; U. Corvera, Carlos; Das, Prajnan; S. Denlinger, Crystal; C. Enzinger, Peter; T. Fanta, Paul; Farjah, Farhood; Gerdes, Hans; K. Gibson, Michael; E. Glasgow, Robert; A. Hayman, James; N. Hochwald, Steven; L. Hofstetter, Wayne; H. Ilson, David; E. Jaroszewski, Dawn; L. Johung, Kimberly; N. Keswani, Rajesh; Kleinberg, Lawrence; Leong, Stephen; P. Ly, Quan; A. Matkowskyj, Kristina; J. McNamara, Michael; F. Mulcahy, Mary; Kumar Paluri, Ravi; Park, Haeseong; A. Perry, Kyle; M. Pimiento, José; A. Poultsides, George; E. Roses, Robert; E. Strong, Vivian; L. Wiesner, Georgia; G. Willett, Christopher; D. Wright, Cameron; R. McMillian, Nicole; A. Pluchino, Lenora

doi:10.6004/jnccn.2019.0033

Public

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Published in Journal of the National Comprehensive Cancer Network • Jul 1, 2019

Authors:

Jaffer A. Ajani

Thomas A. D’Amico

David J. Bentrem

Abstract

Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide. Squamous cell carcinoma is the most common histology in Eastern Europe and Asia, and adenocarcinoma is most common in North America and Western Europe. Surgery is a major component of treatment of locally advanced resec...

Subject

Medicine

Ramucirumab

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!